The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Marx, R. E. (2003) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/s0278-2391(03)00720-1 · Cited by 3,036
Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases
Ruggiero, S. L., Mehrotra, B., Rosenberg, T. J., & Engroff, S. L. (2004) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2004.02.004 · Cited by 2,057
Self-citationMarx, R. E., Sawatari, Y., Fortin, M., & Broumand, V. (2005) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2005.07.010 · Cited by 1,648
Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women
Bone, H. G., Hosking, D., Devogelaer, J.-P., Tucci, J. R., Emkey, R. D., Tonino, R. P., Rodriguez-Portales, J. A., Downs, R. W., Gupta, J., Santora, A. C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030897 · Cited by 1,347
Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma
Berenson, J. R., Lichtenstein, A., Porter, L., Dimopoulos, M. A., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M. J., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602223340802 · Cited by 1,081
Hortobagyi, G. N., Theriault, R. L., Porter, L., Blayney, D., Lipton, A., Sinoff, C., Wheeler, H., Simeone, J. F., Seaman, J., Knight, R. D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612123352401 · Cited by 1,026
Bisphosphonates: mechanisms of action.
Rodan, G. A., & Fleisch, H. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118722 · Cited by 921
Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid.
Wood, J., Bonjean, K., Ruetz, S., Bellahcène, A., Devy, L., Foidart, J. M., Castronovo, V., & Green, J. R. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035295 · Cited by 854
Osteonecrosis of the Jaw and Bisphosphonates
(2005) · New England Journal of Medicine · doi:10.1056/nejm200507073530120 · Cited by 744
Rosen, L. S., Gordon, D., Tchekmedyian, S., Yanagihara, R., Hirsh, V., Krzakowski, M., Pawlicki, M., de Souza, P., Zheng, M., Urbanowitz, G., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.105 · Cited by 729
Osteonecrosis of the Jaw in Multiple Myeloma Patients: Clinical Features and Risk Factors
Badros, A., Weikel, D., Salama, A., Goloubeva, O., Schneider, A., Rapoport, A., Fenton, R., Gahres, N., Sausville, E., Ord, R., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2465 · Cited by 593
Fournier, P. G. J., Boissier, S., Filleur, S., Guglielmi, J., Cabon, F., Colombel, M. C., & Clézardin, P. (2002) · PubMed · Cited by 562
Berenson, J. R., Hillner, B. E., Kyle, R. A., Anderson, K., Lipton, A., Yee, G. C., & Biermann, J. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.06.037 · Cited by 542
Migliorati, C. A., Schubert, M. M., Peterson, D. E., & Seneda, L. M. (2005) · Cancer · doi:10.1002/cncr.21130 · Cited by 489
Bisphosphanates and Oral Cavity Avascular Bone Necrosis
Migliorati, C. A. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.99.132 · Cited by 480
Managing the care of patients with bisphosphonate-associated osteonecrosis
MIGLIORATI, C. A., CASIGLIA, J., EPSTEIN, J., JACOBSEN, P. L., SIEGEL, M. A., & WOO, S.-B. (2005) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2005.0108 · Cited by 468
Comparison of a Single Infusion of Zoledronic Acid with Risedronate for Paget's Disease
Reid, I. R., Miller, P., Lyles, K., Fraser, W., Brown, J. P., Saidi, Y., Mesenbrink, P., Su, G., Pak, J., Zelenakas, K., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044241 · Cited by 439
Ruggiero, S. L., Gralow, J. R., Marx, R. E., Hoff, A. O., Schubert, M. M., Huryn, J. M., Toth, B., Damato, K., & Valero, V. (2006) · Journal of Oncology Practice · doi:10.1200/jop.2.1.7 · Cited by 355
Self-citationPamidronate induces modifications of circulating angiogenetic factors in cancer patients.
Santini, D., Vincenzi, B., Avvisati, G., Dicuonzo, G., Battistoni, F., Gavasci, M., Salerno, A., Denaro, V., & Tonini, G. (2002) · PubMed · Cited by 275
Bisphosphonate Osteochemonecrosis (Bis-Phossy Jaw): Is This Phossy Jaw of the 21st Century?
Hellstein, J. W., & Marek, C. L. (2005) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2005.01.010 · Cited by 270
Bisphosphonates and osteonecrosis of the jaw
Purcell, P. M., & Boyd, I. W. (2005) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2005.tb06762.x · Cited by 202
Avascular necrosis of the jaws: risk factors in metastatic cancer patients
Tarassoff, P., & Csermak, K. (2003) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2003.09.001 · Cited by 175
Starck, W. J., & Epker, B. N. (1995) · PubMed · Cited by 151
Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma
Vannucchi, A. M., Ficarra, G., Antonioli, E., & Bosi, A. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05382.x · Cited by 109
Bisphosphonate-Associated Osteonecrosis of the Jaws and Endodontic Treatment: Two Case Reports
Sarathy, A. P., Bourgeois, S. L., & Goodell, G. G. (2005) · Journal of Endodontics · doi:10.1097/01.don.0000182737.09980.2c · Cited by 87
Zoledronic acid down‐regulates adhesion molecules of bone marrow stromal cells in multiple myeloma
Corso, A., Ferretti, E., Lunghi, M., Zappasodi, P., Mangiacavalli, S., AMICI, M. D., Rusconi, C., Varettoni, M., & Lazzarino, M. (2005) · Cancer · doi:10.1002/cncr.21104 · Cited by 64
Pathophysiology of bone metastases from prostate cancer and the role of bisphosphonates in treatment
Eaton, C. L., & Coleman, R. E. (2003) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(03)00071-9 · Cited by 54
Bisphosphonates – A Word of Caution
Robinson, N., & Yeo, J. (2004) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v33n4p48s · Cited by 49
Ten Years of Alendronate Treatment for Osteoporosis in Postmenopausal Women
Ruggiero, S. L., & Mehrotra, B. (2004) · New England Journal of Medicine · doi:10.1056/nejm200407083510218 · Cited by 40
Self-citationOptimising treatment of bone metastases by Aredia™ and Zometa™
Coleman, R. E. (2000) · Breast Cancer · doi:10.1007/bf02966406 · Cited by 31
Treatment of Paget's Disease — Taming the Wild Osteoclast
Deftos, L. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058184 · Cited by 30
Pozzi, S., Marcheselli, R., Sacchi, S., Quarta, G., Musto, P., Caparrotti, G., Natale, D., Pianezze, G., Polimeno, G., Pitini, V. V., et al. (2005) · Blood · doi:10.1182/blood.v106.11.5057.5057 · Cited by 26
Cited by
Ruggiero, S. L., Dodson, T. B., Fantasia, J., Goodday, R., Aghaloo, T., Mehrotra, B., & O'Ryan, F. (2014) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2014.04.031 · Cited by 2,905
Self-citationKhosla, S., Burr, D., Cauley, J., Dempster, D. W., Ebeling, P. R., Felsenberg, D., Gagel, R. F., Gilsanz, V., Guise, T., Koka, S., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0707onj · Cited by 1,650
Self-citationKhan, A. A., Morrison, A., Hanley, D. A., Felsenberg, D., McCauley, L. K., O'Ryan, F., Reid, I. R., Ruggiero, S. L., Taguchi, A., Tetradis, S., et al. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2405 · Cited by 1,353
Self-citationRuggiero, S. L., Dodson, T. B., Assael, L. A., Landesberg, R., Marx, R. E., & Mehrotra, B. (2009) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2009.01.009 · Cited by 1,328
Self-citation(2007) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2006.11.003 · Cited by 837
Metadata
- Authors
- Ruggiero, S. L., Fantasia, J., & Carlson, E.
- Venue
- Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology
- Publisher
- Elsevier BV
- Published
- 2006-10
- Volume
- 102
- Issue
- 4
- Pages
- 433-441
- ISSN
- 1079-2104 (ISSN-L)
- OpenAlex
- W2010681669
- Cited by
- 507
- References
- 32
- FWCI
- 20.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.